Cellebrite DI Ltd. provides digital intelligence solutions for the public and private sectors globally. The company is headquartered in Petah Tikva, Israel.
| Revenue (TTM) | $514.29M |
| Gross Profit (TTM) | $426.66M |
| EBITDA | $78.43M |
| Operating Margin | 5.30% |
| Return on Equity | 12.40% |
| Return on Assets | 3.92% |
| Revenue/Share (TTM) | $2.09 |
| Book Value | $2.15 |
| Price-to-Book | 5.37 |
| Price-to-Sales (TTM) | 5.56 |
| EV/Revenue | 4.805 |
| EV/EBITDA | 23.96 |
| Quarterly Earnings Growth (YoY) | -67.90% |
| Quarterly Revenue Growth (YoY) | 15.80% |
| Shares Outstanding | $251.34M |
| Float | $112.46M |
| % Insiders | 43.13% |
| % Institutions | 51.29% |
Volatility is currently contracting
New York, New York--(Newsfile Corp. - September 24, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
NEW YORK, Sept. 24, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors Cellebrite DI Ltd.
Law&Crime Network and NewsNation anchor Jesse Weber returns to host; ceremony to stream live to Law&Crime Network's 7.7 million YouTube subscribers during Cellebrite's annual C2C User Summit in April 2027 TYSONS CORNER, Va. and PETAH TIKVA, Israel, Sept.
NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors Cellebrite DI Ltd. (“Cellebrite” or the “Company”) (NASDAQ: CLBT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
New York, New York--(Newsfile Corp. - September 18, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
Purpose-built platform connects customers worldwide with peers and Cellebrite experts into an always-on community TYSONS CORNER, Va. and PETAH TIKVA, Israel, Sept.
New York, New York--(Newsfile Corp. - September 16, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
Cellebrite DI Ltd. (CLBT) Discusses Leadership Transition and Strategic Focus on Growth and Execution Transcript
New York, New York--(Newsfile Corp. - September 14, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
Strategic move strengthens Cellebrite's flagship access, extraction and decoding technology as Cellebrite Labs joins Wade's Innovation Hub TYSONS CORNER, Va. and PETAH TIKVA, Israel, Sept.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on CLBT and any ticker you trade — then tracks every position and per-strategy win rate.
